News

Filter

News briefs: Auxilium/Pfizer accord; Novartis Signifor and RLX030 developments

08-11-2012

US specialty drugmaker Auxilium Pharmaceuticals' (Nasdaq: AUXL) shares fell 7.2% to $18.60 at close of…

Auxilium PharmaceuticalsBiotechnologyCardio-vascularLicensingNovartisOncologyPfizerPharmaceuticalRare diseasesResearchRLX030SigniforXiaflexXiapex

COMPANY SPOTLIGHT

Menarini

Back to top